ELV Elevance HealthcompanySEC Filings & Insider Trading Activity 2026
Latest Elevance Health (ELV) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 6, 2026, a 10-Q quarterly report filed on October 21, 2025, an 8-K current report filed on April 22, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Elevance Health (ELV) (SEC CIK 1156039), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model: Health benefits and insurance services built significantly through mergers, acquisitions, joint ventures, and strategic alliances
- • Emphasis on risks related to integration and liabilities from recent and future business combinations impacting financials and operations
Risk Factors
- • Risk adjustment audits by CMS and HHS OIG awaiting finalization, with potential retroactive payment adjustments impacting financial results
- • Concentration in states like California, NY, Texas, exposed to regional economic downturns affecting enrollment and revenues
Management Discussion & Analysis
- • Revenue details and YoY change not disclosed in provided text
- • Operating gain and margin defined but no actual % figures or changes provided
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • No new or changed risk factors since 2024 Annual Report on Form 10-K
- • Regulatory risk: ongoing potential adverse impact from healthcare laws and government policy changes
Management Discussion & Analysis
- • Revenue $50.1B Q3 2025, up 12.0% YoY ($44.7B Q3 2024); $148.3B YTD, up 13.9% YoY ($130.2B YTD 2024)
- • Operating margin 2.6% Q3 2025 vs 3.1% Q3 2024; YTD margin 4.6% vs 5.5% YoY; Health Benefits margin down to 1.4% Q3 from 4.2% YoY
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • ELV reaffirms 2026 adjusted EPS guidance of at least $25.50 per diluted share, already factoring in potential CMS Medicare Advantage enrollment sanctions
- • 2026 benefit expense ratio guidance reaffirmed at 90.2% ±50 bps — a high ratio signaling continued cost pressure in the medical segment
Item 8.01: Other Events
- • CMS notifying intent to suspend new Medicare Advantage enrollment into ELV's MA-PD plans effective March 31, 2026 — a direct hit to growth pipeline
- • Sanctions tied to risk adjustment data submission noncompliance for dates of service prior to April 3, 2023; ELV revised practices in April 2023 following new CMS guidance
Annual Reports Archive10-K
AI-powered analysis of Elevance Health (ELV) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Elevance Health (ELV) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Elevance Health (ELV) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $156.6B | $171.3B | $177.0B | $199.1B |
| Operating Income | $8.5B | $8.5B | $7.9B | $7.2B |
| Net Income | $6.0B | $6.0B | $6.0B | $5.7B |
| Op. Margin | 5.4% | 5.0% | 4.4% | 3.6% |
| Net Margin | 3.8% | 3.5% | 3.4% | 2.8% |
| Balance Sheet | ||||
| Total Assets | $102.8B | $108.9B | $116.9B | $121.5B |
| Equity | $36.3B | $39.3B | $41.3B | $43.9B |
| ROE | 16.6% | 15.2% | 14.5% | 12.9% |
Source: XBRL financial data from Elevance Health (ELV) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 22, 2026 | — | — | — |
8-K | Mar 10, 2026 | — | Analysis | — |
8-K | Mar 2, 2026 | — | Analysis | — |
8-K | Feb 26, 2026 | — | Analysis | — |
10-K | Feb 6, 2026 | Dec 31, 2025 | Analysis | |
8-K | Jan 28, 2026 | — | — | |
8-K | Dec 10, 2025 | — | — | |
10-Q | Oct 21, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Jul 17, 2025 | Jun 30, 2025 | — | |
10-Q | Apr 22, 2025 | Mar 31, 2025 | — | |
10-K | Feb 20, 2025 | Dec 31, 2024 | — | |
10-Q | Oct 17, 2024 | Sep 30, 2024 | — | |
10-Q | Jul 17, 2024 | Jun 30, 2024 | — | |
10-Q | Apr 18, 2024 | Mar 31, 2024 | — | |
10-K | Feb 21, 2024 | Dec 31, 2023 | — | |
10-Q | Oct 18, 2023 | Sep 30, 2023 | — | |
10-Q | Jul 19, 2023 | Jun 30, 2023 | — | |
10-Q | Apr 19, 2023 | Mar 31, 2023 | — | |
10-K | Feb 15, 2023 | Dec 31, 2022 | — | |
10-Q | Oct 19, 2022 | Sep 30, 2022 | — | |
10-Q | Jul 20, 2022 | Jun 30, 2022 | — | |
10-Q | Apr 20, 2022 | Mar 31, 2022 | — | |
10-K | Feb 16, 2022 | Dec 31, 2021 | — | |
10-Q | Oct 20, 2021 | Sep 30, 2021 | — | |
10-Q | Jul 21, 2021 | Jun 30, 2021 | — |
Frequently Asked Questions
What are the latest ELV SEC filings in 2026?
Elevance Health (ELV) has filed a 10-K annual report on February 6, 2026, a 10-Q quarterly report on October 21, 2025, an 8-K current report on April 22, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ELV file its most recent 10-K annual report?
Elevance Health (ELV) filed its most recent 10-K annual report on February 6, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ELV 10-Q quarterly reports?
Elevance Health (ELV)'s most recent 10-Q quarterly report was filed on October 21, 2025. SignalX displays every ELV 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ELV filed recently?
Elevance Health (ELV)'s most recent 8-K was filed on April 22, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ELV insider trading activity (Form 4)?
SignalX aggregates every ELV Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ELV file with the SEC?
Elevance Health (ELV) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ELV filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Elevance Health (ELV).
What is ELV's SEC CIK number?
Elevance Health (ELV)'s SEC CIK (Central Index Key) number is 1156039. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1156039 to look up all ELV filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ELV return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Elevance Health (ELV) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Elevance Health SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 58+ filings.